Infant Mortality Reduction by the Mass Administration of Azithromycin

Azithromycin is a macrolide-type antibiotic that is used to treat various types of infections. Previous studies in Niger have demonstrated a nearly 18% reduction in all-cause child mortality following biannual mass administration to children 1-59 months.

Matching identical placebo in packaging, appearance, and taste.